Renaissance Technologies’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-52
Closed -$206K – 4493
2022
Q3
$206K Sell
52
-249
-83% -$979K ﹤0.01% 3372
2022
Q2
$785K Sell
301
-146
-33% -$380K ﹤0.01% 2868
2022
Q1
$1.44M Buy
+447
New +$1.92M ﹤0.01% 2471
2021
Q4
– Sell
-41
Closed -$381K – 4295
2021
Q3
$381K Sell
41
-74
-64% -$636K ﹤0.01% 2999
2021
Q2
$1.17M Buy
+115
New +$1.89M ﹤0.01% 2594
2021
Q1
– Sell
-183
Closed -$1.11M – 3797
2020
Q4
$1.11M Buy
183
+29
+19% +$114K ﹤0.01% 2446
2020
Q3
$554K Sell
154
-101
-40% -$363K ﹤0.01% 2777
2020
Q2
$989K Sell
255
-26
-9% -$86.3K ﹤0.01% 2544
2020
Q1
$529K Sell
281
-10
-3% -$37.2K ﹤0.01% 2738
2019
Q4
$1.5M Buy
291
+28
+11% +$107K ﹤0.01% 2451
2019
Q3
$927K Buy
263
+21
+9% +$127K ﹤0.01% 2633
2019
Q2
$2.04M Buy
242
+118
+95% +$1.24M ﹤0.01% 2319
2019
Q1
$1.6M Buy
124
+122
+6,100% +$1.97M ﹤0.01% 2434
2018
Q4
$36K Buy
+2
New +$69.5K ﹤0.01% 3305
2018
Q3
– Hold
0
– – – 3320
2018
Q2
– Sell
-2
Closed -$71K – 3591
2018
Q1
$71K Buy
+2
New +$383K ﹤0.01% 3285
2015
Q1
– Hold
0
– -$54K – 3385
2014
Q4
– Hold
0
– – – 2865

Other funds holding SEEL

Renaissance Technologies's SEEL Position: Q4 2022 in Review

Renaissance Technologies sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 52 shares — an estimated $206K sold.

Renaissance Technologies first reported a position in SEEL in Q1 2018 and held it in 15 quarters. The position peaked at $2.04M in Q2 2019. 64 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.

  • Renaissance Technologies reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 52 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $206K.
  • Renaissance Technologies first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2018 and held it in 15 quarters.
  • Renaissance Technologies's Seelos Therapeutics, Inc. Common Stock position peaked at $2.04M in Q2 2019.
  • 64 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.